New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...
On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
Share on Pinterest The FDA has approved the first GLP-1 pill for weight loss. Bloomberg Creative/Getty Images In December 2025, the U.S. FDA approved an oral pill form of Wegovy for weight loss. Until ...
Digestive problems are some of Zepbound’s more common side effects. These can include nausea, diarrhea, indigestion, and constipation. In studies, these side effects were rarely severe. Serious side ...
Ozempic (semaglutide) helps people with type 2 diabetes lower their blood sugar if diet, exercise, and other diabetes medications haven’t worked. If you’ve just gotten a prescription for it, you might ...
IVF hormone injections are an advanced fertility treatment that helps your ovaries make more eggs, supporting your IVF cycles and achieving healthy eggs. Doctors administer these hormonal injections ...
CellCept (mycophenolate mofetil) is a prescription drug that’s used to help prevent organ rejection after an organ transplant. The most common side effects reported with CellCept include diarrhea and ...
Regeneron Pharmaceuticals, Inc. Fourth quarter 2025 revenues increased 3% to $3.9 billion versus fourth quarter 2024; full year 2025 revenues increased 1% to $14.3 billion versus ...
With 28% of UK adults now classified as obese - and a further 36% overweight - it’s no wonder weight-loss injections have exploded in popularity. An estimated 1.5 million people are already using them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results